OLANZA 10MG BOX OF 90

Olanzapine is indicated for the treatment of schizophrenia.
In patients who initially responded to treatment, olanzapine has demonstrated its effectiveness in maintaining this clinical improvement over the long term.
Olanzapine is indicated for the treatment of moderate to severe manic episodes.
Olanzapine is indicated for the prevention of relapses in patients with bipolar disorder who have previously responded to olanzapine treatment during a manic episode.

Description

Brand / Product Name	OLANZA 10
Dosage	10 mg
Form	Film-coated scoreable tablet
Presentation	Box of 90
Primary Packaging	Blister
Specification	ALU, PA, PVC
INN / Active Ingredient	OLANZAPINE
VEIC Classification	Essential
Therapeutic Class	Nervous System
Sub-class	Psycholeptics
Manufacturer	PHILADELPHIA PHARMA
Schedule	A
Shelf Life	36 months
Generic / Brand	Generic
Marketing Authorization Number	9353034
Marketing Authorization Date	2014-11-28
Range / Line	NeuroPsy Line